查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1815506

2025年免疫血液学全球市场报告

Immunohematology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年免疫血液学市场将强劲成长，到2029年将达到31.7亿美元，复合年增长率为5.7%。预测期内的成长可归因于就地检验需求的不断增长、新型血液製品的出现、医疗保健基础设施的不断扩展、血液相容性基因检测以及血液安全监管支持。预测期内的主要趋势包括自动化和高通量系统、分子血型分型、抗体检测技术、患者血液管理方案、人工智慧与分析技术的整合以及远端医疗的整合。

未来五年5.7%的成长预测比我们先前对该市场的预测略有下降，下降了0.2%。下降的主要原因是美国与其他国家之间的关税影响。预计关税壁垒将扰乱美国医院血库的运营，导致来自美国和法国的自动红血球配型系统和单克隆抗血清试剂成本上升，输血产品的准备时间延长，血液病理学检测服务成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税壁垒的影响也将更加广泛。

预计血液疾病盛行率的上升将在短期内推动免疫血液学市场的成长。影响红血球、白血球、血小板和血浆等血液成分的血液疾病需要使用免疫血液学技术进行安全有效的输血。这可以防止因血型不合或受血者血液中存在抗体而引起的输血反应。免疫血液学技术在影响免疫系统的疾病的诊断和治疗中也发挥关键作用，这些疾病也可能影响血液系统。例如，英国癌症研究中心报告称，英国因血液疾病引起的白血病新病例数预计将从2023-2025年的约12,400例增加到2038-2040年的约14,500例。因此，血液疾病盛行率的上升是支持免疫血液学市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球免疫血液学：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球免疫血液学市场：成长率分析
  • 全球免疫血液学市场表现：规模与成长，2019-2024
  • 全球免疫血液学市场预测：规模与成长，2024-2029 年，2034 年
  • 全球免疫血液学：总目标市场（TAM）

第六章 市场细分

  • 全球免疫血液学市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 分析仪器和系统
  • 试剂
  • 全球免疫血液学市场：依技术、绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 生物晶片
  • 红血球磁化技术（Met）
  • 凝胶卡
  • 微孔盘
  • 聚合酵素链锁反应（PCR）
  • 全球免疫血液学市场：按疾病、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 血液相关疾病
  • HIV
  • 肝炎
  • 全球免疫血液学市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 输血前检测
  • 免疫溶血的调查
  • 周产期检查
  • 血型表型
  • 白血球和血小板血清学检查
  • 全球免疫血液学市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 血库
  • 诊断与参考实验室
  • 医院
  • 学术研究机构
  • 全球免疫血液学市场：按分析仪器和系统细分（按类型）、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 血型分析仪
  • 交叉试验分析仪
  • 凝胶卡系统
  • 全球免疫血液学市场：按试剂类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 血型试剂
  • 抗血清
  • 对照血清

第七章 区域和国家分析

  • 全球免疫血液学市场：区域分析、预测与趋势，2019-2024 年、2024-2029 年、2034 年
  • 全球免疫血液学市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 免疫血液学市场：竞争格局
  • 免疫血液学市场：公司简介
    • Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Grifols SA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Company
  • Merck Co. & KGaA
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Danaher Corporation
  • Biosystems SA
  • Roche Holdings AG
  • Mindray Medical International Limited
  • F.Hoffmann La-Roche Ltd.
  • Biotest AG
  • Cardinal Health Inc.
  • Quotient Limited
  • DiaSorin SpA

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年免疫血液学市场：提供新机会的国家
  • 2029年免疫血液学市场：细分领域带来新机会
  • 2029年免疫血液学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24221u

Immunohematology is a subfield of laboratory medicine that focuses on the study of blood groups and the immune response of the body to foreign substances, particularly in the context of blood transfusions. Immunohematological techniques are employed to identify and address diagnostic issues in patients with hematological conditions, including auto-immune hemolytic anemia.

The main components of immunohematology include analyzers and systems, along with reagents. Analyzers and systems are automated instruments designed for blood typing and antibody screening. Various technologies are utilized in this field, such as biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, and polymerase chain reaction (PCR). These technologies are applied in the treatment of various diseases such as HIV and hepatitis. The diverse applications encompass pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, leucocyte and platelet serology. The end-users of immunohematology products include blood banks, diagnostic and reference laboratories, hospitals, as well as academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The immunohematology market research report is one of a series of new reports from The Business Research Company that provides immunohematology optical components market statistics, including immunohematology optical components industry global market size, regional shares, competitors with a immunohematology optical components market share, detailed immunohematology optical components market segments, market trends and opportunities, and any further data you may need to thrive in the immunohematology optical components industry. This immunohematology optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohematology market size has grown steadily in recent years. It will grow from $2.46 billion in 2024 to $2.55 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to advancements in blood transfusion science, the prevalence of blood disorders, the expansion of blood banks, government initiatives for blood safety, increased surgical procedures, and awareness of transfusion-related risks

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, emergence of novel blood products, expansion of healthcare infrastructure, genetic testing for blood compatibility, and regulatory support for blood safety. Major trends in the forecast period include automation and high-throughput systems, molecular blood typing methods, antibody detection techniques, patient blood management programs, integration of ai in analysis, telemedicine integration.

The forecast of 5.7% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. hospital blood banks by increasing the cost of automated erythrocyte-matching systems and monoclonal antisera reagents sourced from South Korea and France, thereby prolonging transfusion preparation times and elevating hematopathology service costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the prevalence of hematological disorders is set to drive the growth of the immunohematology market in the foreseeable future. Hematological disorders, affecting blood components such as red blood cells, white blood cells, platelets, and plasma, necessitate the use of immunohematology for safe and effective blood transfusions. This helps prevent transfusion reactions arising from incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques also play a crucial role in diagnosing and treating diseases impacting the immune system, with potential implications for the hematological system. For instance, Cancer Research UK reported an expected increase in new leukemia cases due to hematological disorders in the UK, rising from approximately 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Thus, the escalating prevalence of hematological disorders is a key driver behind the growth of the immunohematology market.

The growth of the immunohematology market is anticipated to be driven by the increasing aging population. An aging population refers to a demographic trend marked by a higher proportion of elderly individuals within a society. Immunohematology plays a crucial role in meeting the transfusion needs of this demographic, ensuring the safe use of blood products, and facilitating medical interventions for older adults. For instance, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, this age group's share of the total population is expected to grow from 17% to 23% during the same period. Therefore, the aging population is a significant factor driving the expansion of the immunohematology market.

Leading companies in the immunohematology market are focused on creating innovative diagnostic solutions, such as soluble recombinant proteins that can mitigate the interference caused by the cancer therapy daratumumab. Soluble recombinant proteins are produced using recombinant DNA technology, maintaining their proper structure and functionality in a soluble form within a host cell or solution, making them suitable for research and therapeutic applications. For example, in November 2023, Grifols, S.A., a pharmaceutical company based in Spain, introduced the Grifols sCD38 solution. This product is the first-ever soluble recombinant protein developed specifically to address the interference that daratumumab causes in essential blood transfusion compatibility testing. Targeted at patients with multiple myeloma, this groundbreaking solution prevents daratumumab from binding to CD38 proteins on red blood cells, ensuring accurate pre-transfusion test results. By streamlining the processes of screening, identification, and crossmatching, Grifols sCD38 improves blood transfusion protocols and reduces delays in administering lifesaving transfusions.

Major companies operating in the immunohematology market are innovating by introducing new products such as self-sampling blood collection products to enhance their market profitability. Self-sampling blood collection involves individuals collecting their own blood samples for diagnostic purposes without the need for healthcare professionals. For example, in February 2023, Capitainer launched CapitainerB 50, a self-sampling blood collection device that protects samples from contamination. The microsampling technology employed ensures precise quantitative sampling comparable to conventional pipetting.

In March 2023, Werfen, S.A., a diagnostic care company based in Spain, completed the acquisition of Immucor Inc. for approximately $2 billion. This strategic move aimed to expand Werfen's capabilities in specialized diagnostic testing, particularly within diagnostic solutions. Immucor Inc., a transfusion diagnostics company based in Spain, focuses on providing safe, accessible, and affordable blood tests.

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunohematology market includes revenues earned by entities by providing blood banking and transfusion medicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohematology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunohematology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohematology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohematology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Analyzers And Systems; Reagents
  • 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (Met); Gel Cards; Microplates; Polymerase Chain Reaction (PCR)
  • 3) By Disease: Blood-Related Diseases; HIV; Hepatitis
  • 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
  • 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
  • Subsegments:
  • 1) By Analyzers And Systems: Blood Typing Analyzers; Cross-Matching Analyzers; Gel Card Systems
  • 2) By Reagents: Blood Grouping Reagents; Antisera; Control Serum
  • Companies Mentioned: Ortho Clinical Diagnostics Inc.; Immunocor Inc.; Abbott Laboratories; Siemens Healthineers AG; Grifols S.A.; Beckman Coulter Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson and Company; Merck Co. & KGaA; Bio-Rad Laboratories; Sysmex Corporation; Danaher Corporation; Biosystems S.A.; Roche Holdings AG; Mindray Medical International Limited; F.Hoffmann La-Roche Ltd.; Biotest AG; Cardinal Health Inc.; Quotient Limited; DiaSorin S.p.A.; Lorne Laboratories Ltd.; Biokit S.A.; Avox Technologies; Diagnostic Automation/Cortez Diagnostics Inc.; Inno-train Diagnostik GmbH; Drucker Diagnostics Inc.; Immundia Diagnostics Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunohematology Market Characteristics

3. Immunohematology Market Trends And Strategies

4. Immunohematology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunohematology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunohematology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunohematology Market Growth Rate Analysis
  • 5.4. Global Immunohematology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunohematology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunohematology Total Addressable Market (TAM)

6. Immunohematology Market Segmentation

  • 6.1. Global Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analyzers And Systems
  • Reagents
  • 6.2. Global Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biochips
  • Erythrocyte-Magnetized Technology (Met)
  • Gel Cards
  • Microplates
  • Polymerase Chain Reaction (PCR)
  • 6.3. Global Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood-Related Diseases
  • HIV
  • Hepatitis
  • 6.4. Global Immunohematology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pretransfusion Testing
  • Investigation Of Immune Hemolysis
  • Perinatal Testing
  • Blood Group Phenotyping
  • Leucocyte And Platelet Serology
  • 6.5. Global Immunohematology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Banks
  • Diagnostic And Reference Laboratories
  • Hospitals
  • Academic And Research Institutes
  • 6.6. Global Immunohematology Market, Sub-Segmentation Of Analyzers And Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Typing Analyzers
  • Cross-Matching Analyzers
  • Gel Card Systems
  • 6.7. Global Immunohematology Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Grouping Reagents
  • Antisera
  • Control Serum

7. Immunohematology Market Regional And Country Analysis

  • 7.1. Global Immunohematology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunohematology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunohematology Market

  • 8.1. Asia-Pacific Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunohematology Market

  • 9.1. China Immunohematology Market Overview
  • 9.2. China Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunohematology Market

  • 10.1. India Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunohematology Market

  • 11.1. Japan Immunohematology Market Overview
  • 11.2. Japan Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunohematology Market

  • 12.1. Australia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunohematology Market

  • 13.1. Indonesia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunohematology Market

  • 14.1. South Korea Immunohematology Market Overview
  • 14.2. South Korea Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunohematology Market

  • 15.1. Western Europe Immunohematology Market Overview
  • 15.2. Western Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunohematology Market

  • 16.1. UK Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunohematology Market

  • 17.1. Germany Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunohematology Market

  • 18.1. France Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunohematology Market

  • 19.1. Italy Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunohematology Market

  • 20.1. Spain Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunohematology Market

  • 21.1. Eastern Europe Immunohematology Market Overview
  • 21.2. Eastern Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunohematology Market

  • 22.1. Russia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunohematology Market

  • 23.1. North America Immunohematology Market Overview
  • 23.2. North America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunohematology Market

  • 24.1. USA Immunohematology Market Overview
  • 24.2. USA Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunohematology Market

  • 25.1. Canada Immunohematology Market Overview
  • 25.2. Canada Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunohematology Market

  • 26.1. South America Immunohematology Market Overview
  • 26.2. South America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunohematology Market

  • 27.1. Brazil Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunohematology Market

  • 28.1. Middle East Immunohematology Market Overview
  • 28.2. Middle East Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunohematology Market

  • 29.1. Africa Immunohematology Market Overview
  • 29.2. Africa Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunohematology Market Competitive Landscape And Company Profiles

  • 30.1. Immunohematology Market Competitive Landscape
  • 30.2. Immunohematology Market Company Profiles
    • 30.2.1. Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Immunohematology Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter Inc.
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Becton Dickinson and Company
  • 31.4. Merck Co. & KGaA
  • 31.5. Bio-Rad Laboratories
  • 31.6. Sysmex Corporation
  • 31.7. Danaher Corporation
  • 31.8. Biosystems S.A.
  • 31.9. Roche Holdings AG
  • 31.10. Mindray Medical International Limited
  • 31.11. F.Hoffmann La-Roche Ltd.
  • 31.12. Biotest AG
  • 31.13. Cardinal Health Inc.
  • 31.14. Quotient Limited
  • 31.15. DiaSorin S.p.A.

32. Global Immunohematology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunohematology Market

34. Recent Developments In The Immunohematology Market

35. Immunohematology Market High Potential Countries, Segments and Strategies

  • 35.1 Immunohematology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunohematology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunohematology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer